At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at www.janssen.com/australia. Follow us at @Janssenanz.
> Media Contact
Email: [email protected]
This contact is only for journalists. If you are not a member of the media then please submit your query via www.janssen.com/australia/contact-us.
> News Press Releases
6 December, 2021
Getting Australia to the front of the queue
22 November, 2021
SPRAVATO® (esketamine hydrochloride) nasal spray is now available in Australia for treatment resistant depression
7 September, 2021
Statement from Janssen ANZ MD Biljana Naumovic in response to 5-year Strategic Agreement
Read More about our response to COVID
> 1 July 2021
TREMFYA® on the PBS for Australians with Active Psoriatic Arthritis